Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Revenue

Jerusalem Pharmaceuticals had revenue of $12.88M USD in the quarter ending September 30, 2025, with 29.71% growth. This brings the company's revenue in the last twelve months to $47.15M, up 25.91% year-over-year. In the year 2024, Jerusalem Pharmaceuticals had annual revenue of $39.82M with 0.42% growth.

• Revenue (ttm): $47.15M
• Revenue Growth: +25.91%
• P/S Ratio: 1.77
• Revenue / Employee: $88.80K
• Employees: 531
• Market Cap: 59.20M JOD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.82M	168.20K	0.42%
Dec 31, 2023	39.65M	-6.49M	-14.06%
Dec 31, 2022	46.14M	-82.72K	-0.18%
Dec 31, 2021	46.23M	9.83M	27.00%
Dec 31, 2020	36.40M	2.31M	6.77%